Related Experiment Video
Updated: Jul 12, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Papillomavirus-like particle vaccines.
1Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, MD 20892, USA. schillej@dc37a.nci.nih.gov
Journal of the National Cancer Institute. Monographs
|February 7, 2001
Summary
Papillomavirus-like particle (VLP) vaccines show promise for preventing human papillomavirus (HPV) infections and treating cancer. Research explores L1-only VLPs for prophylaxis and chimeric VLPs for therapeutic responses.
Area of Science:
- Vaccinology
- Structural Biology
- Immunology
Background:
- Papillomavirus-like particle (VLP)-based subunit vaccines have advanced rapidly.
- Three distinct VLP vaccine types are under investigation for various applications.
Purpose of the Study:
- To review the development and potential of VLP-based vaccines.
- To explore L1-only VLPs for HPV infection prevention.
- To examine chimeric VLPs for therapeutic potential against HPV-related cancers and other diseases.
Main Methods:
- Development of L1-only VLPs for inducing neutralizing antibodies against HPV.
- Creation of L1/L2 fusion protein VLPs (chimeric VLPs) to elicit cell-mediated immunity.
- Engineering VLPs with inserted self-peptides to induce autoantibodies for non-HPV related diseases.
Main Results:
- L1-only VLPs induced high serum titers of neutralizing antibodies in preliminary studies.
- Chimeric VLPs generated potent antitumor cytotoxic lymphocyte (CTL) responses in mice.
- VLP-based auto-vaccines demonstrated induction of specific antibodies, blocking viral infection in a proof-of-concept study.
Conclusions:
- VLP-based vaccines offer a versatile platform for both prophylactic and therapeutic applications.
- Further clinical trials are anticipated for L1-only and chimeric VLP vaccines.
- VLP technology holds potential for treating diseases beyond HPV infection.
Related Concept Videos
00:56Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...